MEDIFAST INC 8-K

What Happened

• Medifast, Inc. (MED) filed an 8-K on July 17, 2026 (Item 7.01) to disclose that OPTAVIA, its lifestyle brand and wholly‑owned subsidiary, is being rebranded as "Trilivy," described as a comprehensive metabolic health system.
• The company furnished a press release announcing the rebrand (Exhibit 99.1); the disclosure is furnished under Regulation FD and is not being “filed” for purposes of Section 18 of the Exchange Act.

Key Details

• Date of disclosure: July 17, 2026 (8-K filing).
• Brand change: OPTAVIA → Trilivy; Trilivy described as a "science‑backed metabolic health system."
• Legal note: The press release is furnished as Exhibit 99.1 and the information is furnished (not filed), limiting certain legal liabilities.
• Filing section: Item 7.01 (Regulation FD Disclosure); Exhibit 99.1 attached.

Why It Matters

• A rebrand of a major consumer-facing subsidiary can affect customer recognition, marketing strategy, and brand positioning—factors investors often watch for their potential operational and revenue implications.
• Because the filing only furnishes the press release, Medifast did not provide financial data or forward-looking metrics in this 8-K; investors should look for future filings or company communications for any financial impact, timing, or costs tied to the rebrand.